Zimmer Biomet Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary

Zimmer Biomet Holdings

05/08/2026 13:08

Zimmer Biomet Holdings, Inc. ZBH.N reported quarterly adjusted earnings of $2.07​​ per share for the quarter ended June 30, identical to the same quarter last year.  The mean expectation of twenty five analysts for the quarter was for earnings of $2.01 per share. Wall Street expected results to range from $1.98  to $2.05 per share.
Revenue rose 4.8% to $2.18 billion from a year ago; analysts expected $2.13 billion. 
Zimmer Biomet Holdings, Inc.'s reported EPS for the quarter was $1.03​.
The company reported quarterly net income of $198.3 million.
Zimmer Biomet Holdings, Inc. shares had risen by 11.3% this quarter and gained 6.6% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 0.2% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 8 "strong buy" or "buy," 21 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is  "buy."
Wall Street's median 12-month price target for Zimmer Biomet Holdings, Inc. is $95.00, about 0.9% below its last closing price of $95.81
This summary was machine generated from LSEG data August 5 at 12:08 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
2.01
2.07
Beat
Mar. 31 2026 
1.86
2.09
Beat
Dec. 31 2025 
2.40
2.42
Beat
Sep. 30 2025 
1.87
1.90
Beat